MicroPort NeuroTech™ NUMEN Coil Embolization System Receives Marketing Approval in Japan
Tokyo, Japan, 22 August 2022 – MicroPort Neurotech Limited (“MicroPort NeuroTech™”), a pioneering Chinese company in the field of neurovascular interventional treatment, today announced that it has received marketing approval issued by Ministry of Health, Labour and Welfare Japan for its independently-developed Numen™ Coil Embolization System (“Numen™”), marking the first approved product in Japan for MicroPort NeuroTech™.